Clinical Trial Update: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of Orelabrutinib in adults with systemic lupus erythematosus; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Orelabrutinib (orelabrutinib)

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Systemic Lupus Erythematosus, SLE | Phase 2 | Status: RECRUITING